Callisto Pharmaceuticals is a public biotechnology company that develops novel therapeutics to treat cancer.

Biotechnology

Pharmaceutical

Callisto Pharmaceuticals

Callisto Pharmaceuticals' headquarters in New York, NY, United States

Gary S. Jacob

Bernard F. Denoyer

Robert C. Shepard

Gabriele M. Cerrone

Christoph Bruening

John P. Brancaccio

Stephen K. Carter

Riccardo Dalla-Favera

Randall K. Johnson

The Leadership Team at Callisto Pharmaceuticals is responsible for setting the strategic vision and direction of the company, overseeing the development of innovative cancer therapeutics. They collaborate on research initiatives, manage financial resources, and ensure compliance with regulatory standards, driving the advancement of clinical programs and fostering partnerships to enhance the company's impact in oncology.

Leadership Team

The Clinical Development Team at Callisto Pharmaceuticals is responsible for designing and overseeing clinical trials to evaluate the safety and efficacy of novel cancer therapies. Led by the Chief Medical Officer and supported by the Senior Director of Clinical Operations and a Clinical Trial Advisor, the team collaborates to ensure adherence to regulatory standards, optimize trial protocols, and analyze data to drive innovative treatments from the lab to patients.

��

Callisto Pharmaceuticals

Org chart

Board & advisors

Teams

Leadership Team

Clinical Development Team

Offices

��������

Callisto Pharmaceuticals

Org chart

Board & advisors

Teams

Leadership Team

Clinical Development Team

Offices

Related companies

��